How a data-driven founder used multimodal personal health data and AI to guide treatment decisions during aggressive cancer care.
Key Takeaways
- He aggregated wearables, bloodwork, scans, and journals into Claude for ongoing medical analysis
- His Whoop band predicted immune-system lows before symptoms appeared
- For his scans, Claude estimated a roughly 90% chance of thymic rebound explaining PET uptake